The Panther® System provides the flexibility of multiple
testing options on one integrated solution.
APTIMA COMBO 2
• Worldwide leader in CT/NG testing.
• Provides increased sensitivity compared to DNA tests.
APTIMA TRICHIMONAS VAGINALIS ASSAY
• Only Aptima Trichomonas vaginalis has been shown to detect 100% of TV infection in both symptomatic and asymptomatic patients.
APTIMA HPV ASSAY
• Maximizes the benefits of screening with the same excellent sensitivity as DNA-based assays.
• Minimizes potential harms with fewer false positive results compared to DNA-based testing.
APTIMA HPV 16 18/45 GENOTYPE ASSAY
• First FDA-approved test for HPV 16, 18 and/or 45.
• Adding as a reflex test may pinpoint the genotypes associated with up to 94% of all cervical adenocarcinoma.
APTIMA ZIKA VIRUS ASSAY
• Our commitment to public health with exquisite sensitivity in serum, plasma and urine sample types.
• Two target region design for amplification and detection of Zika virus RNA is an obvious benefit if unexpected mutations arise.
APTIMA HIV-1 QUANT ASSAY
• Full automation meets excellent performance in HIV-1 viral load monitoring.
• A dual target approach against highly conserved regions in the HIV genome, pol and LTR; a sophisticated primer design; and redundancy of oligonucleotides for protection against mutations.
APTIMA HCV QUANT DX ASSAY
• Ultrasensitive, highly precise performance from diagnosis to sustained virologic response.
• High viral load result agreement between Aptima and comparators for
confidence in switching assays without disrupting patient care.